[go: up one dir, main page]

WO2001025430A3 - Nouvelles proteines membranaires humaines - Google Patents

Nouvelles proteines membranaires humaines Download PDF

Info

Publication number
WO2001025430A3
WO2001025430A3 PCT/US2000/027067 US0027067W WO0125430A3 WO 2001025430 A3 WO2001025430 A3 WO 2001025430A3 US 0027067 W US0027067 W US 0027067W WO 0125430 A3 WO0125430 A3 WO 0125430A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel human
membrane proteins
human membrane
nucleotide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/027067
Other languages
English (en)
Other versions
WO2001025430A2 (fr
Inventor
C Alexander Turner
Andrew Olson
Michael Nehls
Glenn Friederich
Brian Zambrowicz
Arthur T Sands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lexicon Pharmaceuticals Inc
Original Assignee
Lexicon Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Genetics Inc filed Critical Lexicon Genetics Inc
Priority to CA002386189A priority Critical patent/CA2386189A1/fr
Priority to EP00967218A priority patent/EP1220912A2/fr
Priority to AU77449/00A priority patent/AU7744900A/en
Priority to JP2001528582A priority patent/JP2003511027A/ja
Publication of WO2001025430A2 publication Critical patent/WO2001025430A2/fr
Publication of WO2001025430A3 publication Critical patent/WO2001025430A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne les séquences de nucléotides et d'acide aminé de plusieurs protéines G humaines couplées à des récepteurs.
PCT/US2000/027067 1999-10-01 2000-10-02 Nouvelles proteines membranaires humaines Ceased WO2001025430A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002386189A CA2386189A1 (fr) 1999-10-01 2000-10-02 Nouvelles proteines membranaires humaines
EP00967218A EP1220912A2 (fr) 1999-10-01 2000-10-02 Nouvelles proteines membranaires humaines
AU77449/00A AU7744900A (en) 1999-10-01 2000-10-02 Novel human membrane proteins
JP2001528582A JP2003511027A (ja) 1999-10-01 2000-10-02 新規ヒト膜タンパク質

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15699699P 1999-10-01 1999-10-01
US60/156,996 1999-10-01

Publications (2)

Publication Number Publication Date
WO2001025430A2 WO2001025430A2 (fr) 2001-04-12
WO2001025430A3 true WO2001025430A3 (fr) 2001-10-18

Family

ID=22561941

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/027067 Ceased WO2001025430A2 (fr) 1999-10-01 2000-10-02 Nouvelles proteines membranaires humaines

Country Status (5)

Country Link
EP (1) EP1220912A2 (fr)
JP (1) JP2003511027A (fr)
AU (1) AU7744900A (fr)
CA (1) CA2386189A1 (fr)
WO (1) WO2001025430A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049096B2 (en) 2001-04-11 2006-05-23 Bristol-Meyers Squibb Company Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015551A1 (fr) * 1997-09-24 1999-04-01 Garvan Institute Of Medical Research Nouveau recepteur

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015551A1 (fr) * 1997-09-24 1999-04-01 Garvan Institute Of Medical Research Nouveau recepteur

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BERKOWITZ DAN E ET AL: "Distribution of beta-3-adrenoceptor mRNA in human tissues.", EUROPEAN JOURNAL OF PHARMACOLOGY MOLECULAR PHARMACOLOGY SECTION, vol. 19, no. 2, 1995, pages 223 - 228, XP000980364, ISSN: 0922-4106 *
DATABASE EMBL SEQUENCE DATABASE 1 May 1999 (1999-05-01), ZENDMAN, A.J.W., ET AL.: "TM7XN1, a novel human EGF-TM7 lie protein , detected with mRNA differential display using human melanoma cell lines with different metastatic potential", XP002157533 *
DATABASE EMBL SEQUENCE LIBRARY 13 March 1998 (1998-03-13), ADAMS, M.D., ET AL.: "homo sapiens chromosome 16 BAC clone CIT987SK-A-152E5", XP002157531 *
DATABASE EMBL SEQUENCE LIBRARY 14 December 1995 (1995-12-14), BOUILLAUD, F.: "study of expressed sequence tags in adipose tissue", XP002157532 *
DATABASE EMBL SEQUENCE LIBRARY 20 July 2000 (2000-07-20), WEI, Y., ET AL.: "pediatric leukemia cDNA sequencing project - unpublished", XP002157534 *
KYAW H ET AL: "CLONING, CHARACTERIZATION, AND MAPPING OF HUMAN HOMOLOG OF MOUSE T-CELL DEATH-ASSOCIATED GENE", DNA AND CELL BIOLOGY,NEW YORK, NY,US, vol. 17, no. 6, 1998, pages 493 - 500, XP000929737, ISSN: 1044-5498 *
ZABALLOS ANGEL ET AL: "Molecular cloning and RNA expression of two new human chemokine receptor-like genes.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 227, no. 3, 1996, pages 846 - 853, XP002157529, ISSN: 0006-291X *
ZILBERFARB V ET AL: "Human immortalized brown adipocytes express functional beta3- adrenoceptor coupled to lipolysis", JOURNAL OF CELL SCIENCE,GB,ESSEX, vol. 110, no. 7, April 1997 (1997-04-01), pages 801 - 807, XP002117551 *

Also Published As

Publication number Publication date
JP2003511027A (ja) 2003-03-25
WO2001025430A2 (fr) 2001-04-12
AU7744900A (en) 2001-05-10
EP1220912A2 (fr) 2002-07-10
CA2386189A1 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
WO1998055508A3 (fr) Proteines humaines ayant des domaines transmembranaires et adn codant ces proteines
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
WO2001042287A3 (fr) Nouvelles proteines membranaires humaines et polynucleotides codant pour ces proteines
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
WO2002026929A3 (fr) Proteine moteur kini-3 et methodes d'utilisation associees
WO1999022005A3 (fr) D-glucosaminyle 3-o-sulfotransferases de sulfate d'heparane et utilisations associees
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2001025430A3 (fr) Nouvelles proteines membranaires humaines
AU1183200A (en) Novel gene encoding brain-specific membrane protein
WO2001087932A3 (fr) Sept protéines transmembranaires et polynucléotides les codant
AU5707498A (en) Novel human membrane protein
AU7846000A (en) Novel human lipase proteins, nucleic acids encoding them, and uses of both of these
WO2001094417A3 (fr) Nouvelles proteines humaines a sept domaines transmembranaires et polynucleotides les codant
WO2002012541A3 (fr) Nouvelles proteines moteurs et leurs procedes d'utilisation
WO2001096593A3 (fr) Nouvelles proteines motrices et procedes d'utilisation de ces proteines
WO2002036633A3 (fr) Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines
WO2001057086A3 (fr) Nouvelles proteines membranaires humaines et les polynucleotides les codant
CA2259640A1 (fr) Vecteur de glycine humaine
WO2002016435A3 (fr) Proteines humaines 7tm et polynucleotides codant ces proteines
WO2001072842A3 (fr) Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines
WO2001029084A3 (fr) Nouvelles proteines humaines et polynucleotides codant pour ces memes proteines
WO2002079479A3 (fr) Nouvelle proteines moteur et procede d'utilisation
WO2002070705A3 (fr) Proteines humaines 7tm et polynucleotides nouveaux codant lesdites proteines
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2386189

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 528582

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 77449/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000967218

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000967218

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000967218

Country of ref document: EP